LISA-TRACKER Rituximab
Product Description
LISA-TRACKER Rituximab is an enzyme linked immunoassay (ELISA) for the quantitative determination of Rituximab (anti-CD20) in human serum samples.
- Comprehensive menu in inflammatory diseases and oncology
- Validated on principle drug and biosimilars
- Ready to use reagents
- Standardised protocols from sample collection to result interpretation
- Automation ready – protocols available on several open platform ELISA systems
-
- Cartron G et al. Pharmacokinetics of rituximab and its clinical use: Thought for the best use? Critical Reviews in Oncology/Hematology 62 (2007) 43-52.
- Huhn D et al. Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood, 2001; 98: 1326-1331.
- Breedveld F et al. Rituximab pharmacokinetics in patients with Rheumatoid Arthritis: B-Cell levels do not correlate with clinical response. Journal of Clinical Pharmacology, 2007; 47:1119-1128.
- Nakou M et al. Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response. Arthritis Research & Therapy 2009, 11:R131.
- Cragg MS et al. A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells. Blood. 2004;104:2540-2542.
- Thurlings RM et al. Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis. Ann Rheum Dis 2010; 69: 409–412.
- Product Code: LTR-002-48
- Number of Tests: 48
- Sample Type: Serum or plasma
- Sample Volume: 100 μL (following predilution)
- Assay Range: 2 – 50 μg/mL
- Add to Enquiry Basket
Interested? Enquire now.
Add to Enquiry Basket
Related Products
| Assays | Certification | Platform | Clinical Area | Portfolio | RUO/IVD |
|---|---|---|---|---|---|
| LISA-TRACKER anti-Rituximab | CE Marked | Therapeutic Drug Monitoring | TDM | IVD | |
| LISA-TRACKER Duo Rituximab | CE Marked | Therapeutic Drug Monitoring | TDM | IVD | |
| LISA-TRACKER Duo Adalimumab | CE Marked | Therapeutic Drug Monitoring | TDM | IVD | |
| LISA-TRACKER Duo Infliximab | CE Marked | Therapeutic Drug Monitoring | TDM | IVD | |
| LISA-TRACKER Duo Certolizumab | CE Marked | Therapeutic Drug Monitoring | TDM | IVD | |
| LISA-TRACKER Duo Etanercept | CE Marked | Therapeutic Drug Monitoring | TDM | IVD | |
| LISA-TRACKER Duo Golimumab | CE Marked | Therapeutic Drug Monitoring | TDM | IVD | |
| LISA-TRACKER Duo Tocilizumab | CE Marked | Therapeutic Drug Monitoring | TDM | IVD |